BrightOwl Loader Loading


  • 20 years of drug and clinical development experience - 5 years in Japan, 13 years in Canada and USA, 2 years in Russia
  • M.D/Ph.D onco-immunologist by training, professional training and strong scientific background in molecular and cellular immunology, cancer, adult stem cells, diabetes and metabolic diseases
  • Clinical Development and Clinical Affairs strong expertise in small molecules, peptides, biologics and biosimilars
  • Creative and critical thinker with strong trouble-shooting and analytical skills
  • An assertive manager with strong interpersonal, communication, negotiation and people management skills. Manages and motivates people to be high-quality performers in demanding, multi-tasking environments
  • Proven experience in giving lectures, presentations to KOL, writing manuscripts, clinical trial protocols, clinical study reports (phase I-IV), patent applications as well as due diligence reports.
  • Superior negotiations skills, ability to see new business opportunities and build persuasive arguments
  • Fluent English, Russian native, Japanese as a second foreign language
  • Canadian citizenship


Current Experience

  • VP, Strategic Development St Petersburg, Saint Petersburg, Russia
    Since August 2013

    Main achievements:

    • Setting-up a brand new Biotechnology unit with its own bioprocesses development, pre-clinical and clinical units
    • Strategic drug and clinical development plan for the company’s portfolio for 3, 5 and 10 years timepoints
    • Initiation of 6 new clinical projects, commencement of 2 clinical trials, approval of 3 marketing authorizations
    • Success in 2 government grants: Biosimilar Lispro and an original peptide-based drug Prostamax

Past Experience

  • VP, Clinical and Regulatory Affairs Vancouver, BC, Canada
    July 2010 --- August 2013


    • Clinical Development of sub-lingual and orally dispersible tablets
    • in-vitro point of care Medical Device Development

  • VP, Drug Development Vancouver, BC, Canada
    July 2007 --- June 2010


    • Drug Development: pre-clinical, clinical and regulatory affairs of original peptide drugs for treatment of idiopathic pulmonary fibrosis, cirrhosis of liver and scleroderma 

  • Senior Scientist Vancouver, BC, Canada
    July 2005 --- May 2007


    • SDF-1 agonist and antagonists as drugs for cardio-vascular and oncology implications


  • MD/PhD in Medicine from Hamamatsu University School of Medicine, Japan in 2001


BrightOwl Assessment:
Self Assessment:
Full Proficiency
Elementary Proficiency

Work Preferences

  • Positions I am interested in:
    Clinical Director Europe Medical Director
  • Work From Home:
  • International:

Area / Region



Driving License
  • Yes